Back
EMXC
iShares MSCI Emerging Markets Ex China ETF
๐ฆ๐บ ASX
๐ Overview
๐ Performance
๐ Holdings
๐ฐ Distributions
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
+ 16.10%
Annual Growth
1 years average annual capital growth
๐ฐ
1.49%
Annual distribution yield
Based on the most recent distribution
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
12
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
EMXC.AX was created on 2024-06-07 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investors with the performance of an index, before fees and expenses.
๐ Performance
Price History
+21.01%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ Top Holdings
Show moreiShares MSCI EM ex-China ETF USD Dis
99.81%
Updated as of 26 September 2025
๐ฐ Distributions
Payouts
๐ฐ Annual Distribution Yield*
1.49%
๐ฐ Annual Distribution Earnings Per $1,000 invested**
$14.86
๐ฐ Most Recent Distribution Franked Percentage Estimate
0.00%
๐ฐ Average Distribution Franked Percentage Estimate
0.00 %
๐ฐ Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Estimate your distribution
If you held
$
of EMXC, your last distribution payment(s) would have been:
$ 58.34
on Fri Jul 11 2025
$ 95.49
on Thu Jan 09 2025
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2025
$0.43
0.00%
2024
$0.00
NaN%
2023
$0.00
0.00%
2022
$0.00
0.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
๐ต Costs
๐ผ
0.25%
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$30.87
๐ฐ Price To Earnings Ratio
0.00
๐ฐ Price To Book Ratio
0.00
๐ฐ Leveraged
No
๐ฐ Inverse
No
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in EMXC
12
๐ Total Capital Earnings
$15K
๐ Average investment frequency
35 weeks
๐ต Average investment amount
$4,673
โฐ Last time a customer invested in EMXC
19 hours
EMXC investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
19%
100k - 150k
50k - 100k
25%
Less than 50k
44%
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
83%
๐ Legal gender of investors
Female
33%
Male
67%
Pearlers who invest in EMXC also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
9.32%
๐ Share price
$111.05 AUD
๐ฆ๐บ AUSTRALIA
๐งฑ MATERIALS
๐ธ FINANCIALS
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
๐ Performance (5Yr p.a)
23.24%
๐ Share price
$67.71 AUD
๐ HIGH PRICE GROWTH
๐บ๐ธ UNITED STATES
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
17.90%
๐ Share price
$150.95 AUD
๐ GLOBAL
๐ค TECHNOLOGY
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
8.04%
๐ Share price
$73.80 AUD
โณ๏ธ DIVERSIFIED
๐ GLOBAL
๐ HIGH PRICE GROWTH
FANG.AX was created on 2020-02-27 by ETFS. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 1413.3m in AUM and 11 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the NYSE FANG.AX+ Index (the Index).
๐ Performance (5Yr p.a)
28.62%
๐ Share price
$35.93 AUD
๐บ๐ธ UNITED STATES
๐ค TECHNOLOGY
๐ COMMUNICATIONS
๐ฐ HIGH DIVIDEND
๐ HIGH PRICE GROWTH
Want more shares? Try these...
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-12-13. The firm is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Companyโs primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
๐ Performance (5Yr p.a)
-5.15%
๐ Share price
$1.93 AUD
๐ฉบ HEALTH CARE